Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2021 and Recent Developments
December 07, 2021 16:05 ET | Avid Bioservices, Inc
-- Recorded Second Quarter Revenue of $26.1 Million -- -- Initiated Strategic Expansion into Viral Vector Development and Manufacturing Services for Cell and Gene Therapy -- -- Signed $36 Million in...
22157.jpg
Global Cell & Gene Therapies Outsourcing Market Outlook Report 2021-2026
November 17, 2021 08:58 ET | Research and Markets
Dublin, Nov. 17, 2021 (GLOBE NEWSWIRE) -- The "Cell & Gene Therapies Market Outlook" report has been added to ResearchAndMarkets.com's offering. This report provides an overview of the current...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Appoints Elie G. Hanania, Ph.D., as Vice President, Process Development, Viral Vector Technologies
November 04, 2021 08:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
22157.jpg
Global RNAi Technologies, Companies & Markets Report 2021-2028: 168 Companies with 231 Collaborations - 34 are Developing RNAi-based Therapeutics and 36 are Involved in microRNAs
November 04, 2021 06:58 ET | Research and Markets
Dublin, Nov. 04, 2021 (GLOBE NEWSWIRE) -- The "RNAi - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. The markets for...
22157.jpg
Global Transfection Reagents and Equipment Market (2021 to 2026) - Growth, Trends, COVID-19 Impact and Forecasts
October 25, 2021 06:43 ET | Research and Markets
Dublin, Oct. 25, 2021 (GLOBE NEWSWIRE) -- The "Transfection Reagents and Equipment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Announces Expansion into Viral Vector Development and Manufacturing Services for Cell and Gene Therapy
October 14, 2021 08:05 ET | Avid Bioservices, Inc
Leverages Established Track Record of Excellence in Biologics CGMP Manufacturing to Address the Rapidly Growing Cell and Gene Therapy Market World-Class Viral Vector Development and Manufacturing...
22157.jpg
Global Gene Delivery Technologies Market Report 2021: Market is Expected to Reach $7.9 Billion by 2028 - Rising Number of Regulatory Approvals for Advance Therapy Products
October 06, 2021 10:18 ET | Research and Markets
Dublin, Oct. 06, 2021 (GLOBE NEWSWIRE) -- The "Global Gene Delivery Technologies Market 2021-2028" report has been added to ResearchAndMarkets.com's offering. The global gene delivery technologies...
22157.jpg
Global Viral Vectors and Plasmid DNA Manufacturing Market Forecasts 2021-2028: A USD 1,866.90 Million Market by 2028
October 01, 2021 05:48 ET | Research and Markets
Dublin, Oct. 01, 2021 (GLOBE NEWSWIRE) -- The "Viral Vectors And Plasmid DNA Manufacturing Market Size By Product Type, By Application, By End Product, By Geographic Scope And Forecast" report has...
22157.jpg
Global Advanced Therapy Medicinal Products (ATMPs) Market Report 2021-2028 - Growing Competition Among Market Players & Increase in Number of Clinical Trials
September 23, 2021 04:33 ET | Research and Markets
Dublin, Sept. 23, 2021 (GLOBE NEWSWIRE) -- The "Global Advanced Therapy Medicinal Products Market 2021-2028" report has been added to ResearchAndMarkets.com's offering. The global advanced therapy...
22157.jpg
Global CRISPR Markets, 2021-2026 - Rapid Increase in Genetic Disorders to Expand Market Demand
September 21, 2021 03:48 ET | Research and Markets
Dublin, Sept. 21, 2021 (GLOBE NEWSWIRE) -- The "CRISPR Market - Forecasts from 2021 to 2026" report has been added to ResearchAndMarkets.com's offering. The global CRISPR market is evaluated at...